Why Current Detection of Vascular Calcification Falls Short and How to Improve on It [0.03%]
当前血管钙化检测为何不足及如何改进
Anouk Gentier,Mueez Aizaz,Maurice Halder et al.
Anouk Gentier et al.
Vascular calcification is a common phenomenon in various vascular diseases, where its presence heralds increased occurrence of adverse disease events, which invariably lead to increased morbidity and mortality in patients. Although the impa...
Increased Platelet Adhesiveness in Patients with Venous Thromboembolic Disease [0.03%]
静脉血栓形成患者的血小板黏附能力增强现象
Julia Martinez-Sanchez,Sergi Torramade-Moix,Ana Belén Moreno-Castaño et al.
Julia Martinez-Sanchez et al.
Background Association between global platelet function and the risk of venous thromboembolic disease (VTE) has been proposed, though the mechanisms do not involve increased platelet aggregation. However, platelet adhesiveness has not been ...
Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical Points [0.03%]
治疗剂量的未分段肝素的管理：关键点叙述性回顾
Isabelle Gouin-Thibault,Alexandre Mansour,Michael Hardy et al.
Isabelle Gouin-Thibault et al.
Nowadays, unfractionated heparin (UFH) use is limited to selected patient groups at high risk of both bleeding and thrombosis (patients in cardiac surgery, in intensive care unit, and patients with severe renal impairment), rendering its ma...
Impact of Clinical Decision Support with Mandatory versus Voluntary Venous Thromboembolism Risk Assessment in Hospitalized Patients [0.03%]
强制和自愿进行临床决策支持对住院患者静脉血栓栓塞风险评估的影响
Vinita Bahl,Marc J Moote,Hsou Mei Hu et al.
Vinita Bahl et al.
Background Venous thromboembolism (VTE) causes significant preventable morbidity and mortality in hospitalized patients. Assessing VTE risk is essential to initiating appropriate prophylaxis and reducing VTE outcomes. Studies show that comp...
An Intestinal Microbiome Intervention Affects Biochemical Disease Activity in Patients with Antiphospholipid Syndrome [0.03%]
肠道微生物组干预影响抗磷脂综合征患者生化疾病活动度
Valérie L B I Jansen,Dagmar J M van Mourik,Mark Davids et al.
Valérie L B I Jansen et al.
Background The origin of autoantibodies in patients with antiphospholipid syndrome (APS) is unknown. The gut microbiome contributes to autoimmunity and contains peptide homologues to the main APS autoantigen, which affect disease activity i...
Corrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation [0.03%]
特发部位、治疗适应证及开始用药时间指导下的抗栓药使用者出血风险预测的订正公告
Vinai Bhagirath,Tanya Kovalova,Jia Wang et al.
Vinai Bhagirath et al.
[This corrects the article DOI: 10.1055/a-2259-1134.]. The Author(s). This is an open access article published by Thieme under the terms of the Creative ...
Establishing Expectancy Values for Fibrin Monomer in Uncomplicated Pregnancy [0.03%]
建立未并发症妊娠纤维蛋白单体的预期值
Holger Seidel,Melina Duncklenberg,Hans-Jörg Hertfelder et al.
Holger Seidel et al.
Background During pregnancy, a physiological increase of molecular activation markers (MAM) of hemostasis such as prothrombin fragments 1 + 2, thrombin-antithrombin complex, and D-dimers (DD) occurs. Therefore, monitoring MAM levels during ...
Use of Magnetic Resonance Direct Thrombus Imaging for the Diagnostic Management of Suspected Thrombosis in Routine Clinical Practice [0.03%]
磁共振直接血栓成像在日常医疗实践中的应用：疑似血栓患者诊断治疗课题研究
Cindy M M de Jong,Lisette F van Dam,Charlotte E A Dronkers et al.
Cindy M M de Jong et al.
Background The noninvasive magnetic resonance direct thrombus imaging (MRDTI) technique can be used to diagnose acute deep vein thrombosis (DVT), without the use of intravenous contrast. MRDTI holds the potential to differentiate between ac...
Epidemiology, Treatment Patterns, and Cost Analysis of Immune Thrombocytopenia in Spain between 2014 and 2020: A Population-based Study [0.03%]
2014年至2020年期间西班牙免疫性血小板减少症的流行病学、治疗模式和成本分析：一项基于人群的研究
Tomás J González-López,Gabriela Alperovich,Elena Burillo et al.
Tomás J González-López et al.
Background Immune thrombocytopenia (ITP) is characterised by low platelet counts and often leads to bleeding, fatigue, and reduced health-related quality of life. Methods This observational, retrospective, population-based study using BIG-P...
Reduced Volume and Faster Infusion Rate of Activated Prothrombin Complex Concentrate: A Phase 3b/4 Trial in Adults with Hemophilia A with Inhibitors [0.03%]
体积更小且输注速度更快的活化凝血酶原复合浓缩剂：A型血友病伴抑制物成人的3b/4期临床试验
Bülent Zülfikar,Johnny Mahlangu,Salim Mohamed Nekkal et al.
Bülent Zülfikar et al.
Background Activated prothrombin complex concentrate (aPCC) is indicated for bleed treatment and prevention in patients with hemophilia with inhibitors. The safety and tolerability of intravenous aPCC at a reduced volume and faster infusion...